The activation of EGFR in liver disease affects liver regeneration via the downstream signaling pathway Ras-Raf-MEK-ERK1/2, and it controls the phosphatidylinositol-3-kinase (PI3K)-Akt mechanism [10]. This evidence concerns the gene EGFR and liver disorder.